APAX Apax Global Alpha

Hardman & Co Research on Apax Global Alpha (APAX): AGA passed inflexion point with deal activity rising

Hardman & Co Research
Hardman & Co Research on Apax Global Alpha (APAX): AGA passed inflexion point with deal activity rising

30-Jan-2025 / 15:40 GMT/BST
The issuer is solely responsible for the content of this announcement.


Hardman & Co Research on Apax Global Alpha (APAX):

AGA passed inflexion point with deal activity rising

 

As noted in our reports, and , the stock of exit-able businesses is rebuilding at a time when market demand is returning. Apax Funds appear to have turned the corner, and both exit and investment activity is steadily rebuilding to more normal levels. In this note, we analyse the likely impact of the exit trend on i) NAV, with an expected greater correlation between EBITDA growth and NAV growth, ii) cashflows, iii) sentiment, and iv) the discount to NAV. In our view, the growing investment, with the operational improvements that Apax then delivers, are key drivers to long-term outperformance.

 

Please click on the link below for the full report:

 

If you are interested in meeting the company, you can register your interest by clicking on the above link.

To contact us:

Hardman & Co
9 Bonhill Street

London

EC2A 4DJ

Follow us on X @HardmanandCo

Contact:

Mark Thomas



 

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

2078335  30-Jan-2025 

fncls.ssp?fn=show_t_gif&application_id=2078335&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
30/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Apax Global Alpha

Mark Thomas
  • Mark Thomas

Apax Global Alpha - AGA passed inflexion point with deal activity risi...

As noted in our reports, 'CM day: further proof of value added by Apax' and '1H’24: deal activity coming back strongly', the stock of exit-able businesses is rebuilding at a time when market demand is returning. Apax Funds appear to have turned the corner, and both exit and investment activity is steadily rebuilding to more normal levels. In this note, we analyse the likely impact of the exit trend on i) NAV, with an expected greater correlation between EBITDA growth and NAV growth, ii) cashflow...

 PRESS RELEASE

Hardman & Co Research on Apax Global Alpha (APAX): AGA passed inflexi...

Hardman & Co Research Hardman & Co Research on Apax Global Alpha (APAX): AGA passed inflexion point with deal activity rising 30-Jan-2025 / 15:40 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on Apax Global Alpha (APAX): AGA passed inflexion point with deal activity rising   As noted in our reports, and , the stock of exit-able businesses is rebuilding at a time when market demand is returning. Apax Funds appear to have turned the corner, and both exit and investment activity is steadily rebuilding to more normal levels...

Brian Moretta ... (+3)
  • Brian Moretta
  • Mark Thomas
  • Martin Hall

Hardman & Co Monthly: January 2025

Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from pro...

Pedro Fonseca
  • Pedro Fonseca

Apax Global Alpha - Transaction activity picked up in Q324

Apax Global Alpha (AGA) reported a Q324 NAV total return (TR) of 1.7% in euro terms on a constant currency basis (-0.2% including fx changes), with a 3.2pp positive contribution from earnings momentum across its private equity (PE) investments. The company experienced a pick-up in new investments, and also saw some positive trends on the realisation front. Following recent exits and accounting for the take-private transaction of Thoughtworks, AGA’s pro-forma exposure to listed holdings has been ...

Mark Thomas ... (+2)
  • Mark Thomas
  • Martin Hall

The Hardman & Co Monthly: November 2024

Feature article: “ROOM” (Running Out of Money) risk, How managing liquidity risk can sustain corporate value and maintain shareholder confidence As we come close to the end of a very challenging year for many UK entrepreneurs, as well as a frustrating period for shareholders, it is time to address one elephant in the ROOM! ROOM stands for “Running Out of Money”. The risk of doing so, or the perception that it could occur, can destroy corporate values and prematurely paralyse a business. While ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch